Home/Filings/4/0001193125-25-244560
4//SEC Filing

Duarte Ira 4

Accession 0001193125-25-244560

CIK 0000818033other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 11:42 AM ET

Size

27.4 KB

Accession

0001193125-25-244560

Insider Transaction Report

Form 4
Period: 2025-10-19
Duarte Ira
EVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-193,87434,869 total
    Exercise: $0.00Common Stock (3,874 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-19+3,874168,092 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001488864

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 11:42 AM ET
Size
27.4 KB